IB Net Payout Yields Model

Invest like me - only at Covestor.com

Blue Apron: Oprah Momemt

By -

Blue Apron (APRN) has soared above $1 following news that the company has a partnership with Weight Watchers International (WTW). The move makes one wonder whether the partnership will lead to Oprah Winfrey pushing Blue Apron products. If so, investors can only dream of the same boost provided to Weight Watchers following their deal with Oprah. Beginning on October 1, 2015, the stock surged over 1,500% in the next 3 years.



No indication exists that Oprah will be involved in pushing the Blue Apron products, but the stock is obviously ripe for a rally on any improving business prospects. The CEO even went as far to tell the WSJ that the deal would stabilize customers counts and turn the company profitable next year. For a company with a $200 million market and revenue over $600 million, the stock might just rally with or without Oprah.

Blue Apron is a high risk at this point, but basically an option play that could pay off.

1/15/19 Update

The company forecasts that Q1 and all of 2019 will be EBITDA positive. The company lost $18.8 million in Q3 so Blue Apron has to generate substantial improvements in EBITDA in the matter of 2 quarters to achieve this goal.

The biggest issue is that the company is only going to be modestly EBITDA positive. The company doesn't have any interest charges so being EBITDA positive is a relatively clear number outside of about $8.5 million in quarterly depreciation and amortization costs. These depreciation charges are likely due to fulfillment facilities that don't need to be expanded at this point.


Blue Apron is definitely making positive moves to improve the business. The value of the stock remains in question without some meaningful catalyst.

Disclosure: No position mentioned. Please review the disclaimer page for more details. 

Comments

Jennifer said…
very good information
July 4, 2019 at 5:02 AM
Post a Comment

Popular posts from this blog

Aurora Cannabis: Deal Or No Deal

By -
Aurora Cannabis was left out of the major deal making in 2018. The cannabis company updated FQ2 guidance to revenues of $50 to $55 million with a continued focus on pure production growth. The stock is down as the market is becoming less impressed with commodity farming operations due to the prime Oregon example. The stock is below key resistance at $5.40 as medical cannabis patient totals failed to impress. As the end of 2018 came and went,   Aurora Cannabis   ( ACB ) was a notable absentee from the deal making in the cannabis market. Just about all of the other major Canadian cannabis players got large investments or signed up powerful partnerships, but the related stocks didn't generally maintain rallies following the deals. Based on the early legalization data in Canada and Oregon, the best option for Aurora Cannabis might actually be selling production capacity while the Canadian market remains hot. Read the full article on Seeking Alpha.  Disclosure: No
Read more

C3.ai: Out Of Steam (Rating Downgrade)

By -
Image
This idea was discussed in more depth with members of my private investing community, Out Fox The Street.  Learn More »   Update - June 23, 2023 C3.ai has fallen back to earth after the Investor Day meeting. The Deutsche Bank analyst call on the meeting suggests the company still isn't ready to produce actual numbers from the generative AI demand.  C3.ai ( NYSE: AI ) shares  fell more than 8%  on Friday after investment firm Deutsche Bank reiterated its sell rating on the enterprise software company after it held its investor meeting. Analyst Brad Zelnick said the event "left a lot to be desired" as there were  no details on financials, "limited" updates on the company's operations and investors did not really attend the event, despite it being positioned as for them. "While we appreciate the vast opportunity presented by AI, the event did nothing to ease our skepticism on the true differentiation of the company's platform, its traction with custome
Read more

Archer Aviation: Promising Developments

By -
Image
  Update - June 12, 2023 Archer is finally in the midst of a breakout on the positive FAA news.  -The acting administrator of the Federal Aviation Administration, Billy Nolen, is in talks to join Archer Aviation (NYSE:ACHR), per a report from Reuters. -Citing sources familiar with the situation, the report indicates Nolen will depart his current position atop the FAA in the next few weeks and will then look to transition to a role at Archer (ACHR). Archer’s rival Joby Aviation (JOBY) previously appointed former FAA chief Michael Huerta to a position on its board in March. Original article posted on Jan. 19 This idea was discussed in more depth with members of my private investing community, Out Fox The Street.  Learn More »   Archer Aviation Inc. jumped to $3 on the excitement of small insider purchases. The eVTOL manufacturer recently announced several major developments towards FAA certification and production of the Midnight aircraft. Archer Aviation stock is interesting, with a $70
Read more